Financial Ratios

FERMENTA BIOTECH LTD.

NSE : NABSE : 506414ISIN CODE : INE225B01021Industry : Pharmaceuticals & DrugsHouse : Private
BSE182.004.75 (+2.68 %)
PREV CLOSE ( ) 177.25
OPEN PRICE ( ) 177.30
BID PRICE (QTY) 178.55 (16)
OFFER PRICE (QTY) 182.00 (63)
VOLUME 15122
TODAY'S LOW / HIGH ( )175.80 183.40
52 WK LOW / HIGH ( ) 132.3214
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)-19.9410.4818.0122.07120.30
   CEPS(Rs)-11.4418.6924.6127.2544.41
   DPS(Rs)1.251.252.505.001.25
   Book NAV/Share(Rs)111.17132.17124.26106.26260.06
   Tax Rate(%)1.9728.9617.81-33.918.89
Margin Ratios
   Core EBITDA Margin(%)11.9619.7725.3822.8231.58
   EBIT Margin(%)-11.3115.6422.0822.5735.19
   Pre Tax Margin(%)-17.8410.9716.9615.8229.93
   PAT Margin (%)-17.497.7913.9421.1927.27
   Cash Profit Margin (%)-10.0413.9019.0426.1630.20
Performance Ratios
   ROA(%)-8.054.088.0511.5429.26
   ROE(%)-16.398.1815.6323.3672.78
   ROCE(%)-6.299.8514.5413.8343.46
   Asset Turnover(x)0.460.520.580.541.07
   Sales/Fixed Asset(x)1.071.281.562.075.73
   Working Capital/Sales(x)8.313.023.243.102.92
Efficiency Ratios
   Fixed Capital/Sales(x)0.940.780.640.480.17
   Receivable days102.78100.6484.9686.8729.71
   Inventory Days132.79123.42120.58122.2079.07
   Payable days142.23115.51137.08200.0389.50
Valuation Parameters
   PER(x)0.0019.6213.899.642.28
   PCE(x)-9.3511.0110.177.816.18
   Price/Book(x)0.961.562.012.003.16
   Yield(%)1.170.611.002.350.15
   EV/Net Sales(x)1.432.062.442.672.16
   EV/Core EBITDA(x)10.039.478.989.695.66
   EV/EBIT(x)-12.6513.1711.0511.826.13
   EV/CE(x)0.701.051.271.401.64
   M Cap / Sales0.941.531.942.041.87
Growth Ratio
   Net Sales Growth(%)-15.224.0624.06-25.743135.24
   Core EBITDA Growth(%)-44.38-16.7922.48-46.361813.40
   EBIT Growth(%)-161.30-26.3021.40-52.381210.03
   PAT Growth(%)-290.27-41.82-18.38-42.30556.86
   EPS Growth(%)-290.20-41.82-18.38-81.65214.21
Financial Stability Ratios
   Total Debt/Equity(x)0.680.620.640.720.87
   Current Ratio(x)1.171.621.541.521.88
   Quick Ratio(x)0.701.000.920.911.32
   Interest Cover(x)-1.733.354.313.356.69
   Total Debt/Mcap(x)0.690.390.310.350.28

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.